{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:53:54Z","timestamp":1790013234112,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jid.2016.01.025","type":"journal-article","created":{"date-parts":[[2016,2,7]],"date-time":"2016-02-07T11:46:24Z","timestamp":1454845584000},"page":"1124-1129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["A Randomized-Controlled Trial of Oral Low-Dose Isotretinoin for Difficult-To-Treat Papulopustular Rosacea"],"prefix":"10.1016","volume":"136","author":[{"given":"Emilie","family":"Sbidian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric","family":"Vicaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Chidiack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Anselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Cribier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Dr\u00e9no","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chosidow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2016.01.025_bib1","first-page":"27","article-title":"The pharmacologic therapy of rosacea: a paradigm shift in progress","volume":"75","author":"Bikowski","year":"2005","journal-title":"Cutis"},{"key":"10.1016\/j.jid.2016.01.025_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/1523-1747.ep12365600","article-title":"Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness","volume":"107","author":"Chren","year":"1996","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.01.025_bib3","first-page":"21","article-title":"Rosacea subtypes: a treatment algorithm","volume":"74","author":"Dahl","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.jid.2016.01.025_bib4","first-page":"134","article-title":"Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea","volume":"93","author":"Del Rosso","year":"2014","journal-title":"Cutis"},{"key":"10.1016\/j.jid.2016.01.025_bib5","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jclinepi.2014.05.015","article-title":"Rationale for unequal randomization in clinical trials is rarely reported: a systematic review","volume":"67","author":"Dibao-Dina","year":"2014","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jid.2016.01.025_bib6","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archderm.134.7.884","article-title":"Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea","volume":"134","author":"Erdogan","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2016.01.025_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archderm.1994.01690030051008","article-title":"A\u00a0comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea","volume":"130","author":"Ertl","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2016.01.025_bib8","first-page":"505","article-title":"Systemic isotretinoin in the treatment of rosacea\u2014doxycycline- and placebo-controlled, randomized clinical study","volume":"8","author":"Gollnick","year":"2010","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.jid.2016.01.025_bib9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MD.0b013e3181dfca14","article-title":"Use of thalidomide for severe recurrent aphthous stomatitis: a multicenter cohort analysis","volume":"89","author":"Hello","year":"2010","journal-title":"Medicine"},{"key":"10.1016\/j.jid.2016.01.025_bib10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2230.2004.01472.x","article-title":"Continuous \u2018microdose\u2019 isotretinoin in adult recalcitrant rosacea","volume":"29","author":"Hofer","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2016.01.025_bib11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1365-4362.1986.tb04533.x","article-title":"Treatment of rosacea with isotretinoin","volume":"25","author":"Hoting","year":"1986","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2016.01.025_bib12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-2133.1975.tb02252.x","article-title":"A\u00a0follow-up of tetracycline-treated rosacea. With special reference to rosacea keratitis","volume":"93","author":"Knight","year":"1975","journal-title":"Br J Dermatol"},{"issue":"120","key":"10.1016\/j.jid.2016.01.025_bib13","first-page":"5","article-title":"Roaccutan in acne and rosacea","volume":"60","author":"Mahrle","year":"1985","journal-title":"Z\u00a0Hautkr"},{"key":"10.1016\/j.jid.2016.01.025_bib14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2230.1984.tb00842.x","article-title":"Response of rosacea to isotretinoin","volume":"9","author":"Marsden","year":"1984","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2016.01.025_bib15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaad.2014.05.036","article-title":"The psychological impact of rosacea and the influence of current management options","volume":"71","author":"Moustafa","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.01.025_bib16","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0190-9622(82)70067-2","article-title":"Action of isotretinoin in acne rosacea and gram-negative folliculitis","volume":"6","author":"Plewig","year":"1982","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.01.025_bib17","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMcp042829","article-title":"Clinical practice","volume":"352","author":"Powell","year":"2005","journal-title":"Rosacea. N Engl J Med"},{"key":"10.1016\/j.jid.2016.01.025_bib18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/bjd.14058","article-title":"Understanding rosacea","volume":"173","author":"Powell","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2016.01.025_bib19","first-page":"1123","article-title":"Treatment of rosacea with isotretinoin. Results of a multicenter trial follow-up","volume":"62","author":"Schell","year":"1987","journal-title":"Z\u00a0Hautkr"},{"key":"10.1016\/j.jid.2016.01.025_bib20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(02)07750-4","article-title":"Allocation concealment in randomised trials: defending against deciphering","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2016.01.025_bib21","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2133.2012.11037.x","article-title":"A\u00a0study on the epidemiology of rosacea in the U.K","volume":"167","author":"Spoendlin","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2016.01.025_bib22","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2013.04.043","article-title":"Rosacea: current state of epidemiology","volume":"69","author":"Tan","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.01.025_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0733-8635(05)70147-9","article-title":"Acne and rosacea. New and emerging therapies","volume":"18","author":"Thiboutot","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jid.2016.01.025_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2340\/00015555678991","article-title":"Isotretinoin treatment of rosacea","volume":"67","author":"Turjanmaa","year":"1987","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2016.01.025_bib25","first-page":"CD003262","article-title":"Interventions for rosacea","volume":"4","author":"van Zuuren","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jid.2016.01.025_bib26","first-page":"CD003262","article-title":"Interventions for rosacea","volume":"3","author":"van Zuuren","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jid.2016.01.025_bib27","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.01.025_bib28","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jaad.2004.01.048","article-title":"Standard grading system for rosacea: report of the National Rosacea Society Expert\u00a0Committee on the Classification and Staging of Rosacea","volume":"50","author":"Wilkin","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.01.025_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","article-title":"Acne vulgaris","volume":"379","author":"Williams","year":"2012","journal-title":"Lancet"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X16004607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X16004607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T06:51:37Z","timestamp":1718347897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X16004607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0022202X16004607"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2016.01.025","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Randomized-Controlled Trial of Oral Low-Dose Isotretinoin for Difficult-To-Treat Papulopustular Rosacea","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2016.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}